Clinical Trials on Neurofibromatosis Type 2
Total 57298 results
-
NYU Langone HealthNovartis Pharmaceuticals; The Children's Tumor FoundationCompletedNeurofibromatosis Type IIUnited States
-
University of UtahUniversity of British Columbia; Children's Hospital Medical Center, Cincinnati and other collaboratorsTerminatedNeurofibromatosis Type 1 (NF1)United States, Canada
-
Massachusetts Eye and Ear InfirmaryRecruiting
-
National Institute of Neurological Disorders and...Recruiting
-
National Cancer Institute (NCI)CompletedPlexiform Neurofibroma | Neurofibromatosis Type IUnited States
-
Manchester University NHS Foundation TrustCompletedNeurofibromatosis Type 2United Kingdom
-
PTC TherapeuticsUnited States Department of DefenseTerminated
-
NYU Langone HealthCompletedNeurofibromatosis 1 and 2 (NF1 and NF2)United States
-
Novartis PharmaceuticalsTerminatedPlexiform Neurofibroma Associated With Neurofibromatosis Type 1Israel
-
University of Alabama at BirminghamCompletedNeurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PNUnited States
-
NYU Langone HealthGlaxoSmithKlineCompletedNeurofibromatosis 2 | Vestibular SchwannomaUnited States
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramRecruitingNeurofibromatosis 1 | Neurofibromatosis Type 1 | Cutaneous Neurofibroma | Neurofibromatosis (Nonmalignant)United States
-
Recursion Pharmaceuticals Inc.RecruitingNeurofibromatosis Type 2United States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsTerminatedNeuroma, Acoustic | Neurofibromatosis Type 2United States
-
NYU Langone HealthCompletedNeurofibromatosis Type 2 | Vestibular SchwannomasUnited States
-
Li PengBetta Pharmaceuticals Co., Ltd.CompletedNeurofibromatosis Type 2 | Vestibular SchwannomaChina
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 2 | Vestibular SchwannomaUnited States
-
Beijing Tiantan HospitalShandong Simcere-Medgenn Bio-pharmaceutical Co., LtdCompletedNeurofibromatosis Type 2 | Vestibular SchwannomaChina
-
University of Alabama at BirminghamMemorial Sloan Kettering Cancer CenterActive, not recruitingNeurofibromatosis 2 | Progressive Vestibular Schwannoma (VS)United States
-
University of Alabama at BirminghamGenentech, Inc.CompletedNeurofibromatosis Type 2 | Progressive Vestibular SchwannomasUnited States
-
University Hospital TuebingenNational Center for Tumor Diseases, HeidelbergCompletedNeurofibromatosis Type 2 | Vestibular Schwannoma | Acoustic NeuromaGermany
-
SpringWorks Therapeutics, Inc.Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
AstraZenecaRecruitingNeurofibromatosis Type 1Portugal, Spain, United Kingdom, Israel, France, Italy, Switzerland, Germany, Austria
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingType I NeurofibromatosisChina
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Legius SyndromeUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedNeurofibromatosis Type 1France
-
Children's National Research InstituteEmory University; University of Texas Southwestern Medical Center; Arizona State...Completed
-
Shriners Hospitals for ChildrenUniversity of Utah; Thrasher Research FundCompletedNeurofibromatosis Type 1United States
-
University Hospital, ToulouseUnknownNeurofibromatosis Type 1France
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington... and other collaboratorsCompletedNeurofibromatosis Type 1United States, Australia
-
Tel-Aviv Sourasky Medical CenterUnknownNeurofibromatosis Type 1
-
Ann & Robert H Lurie Children's Hospital of ChicagoNational Institute of Neurological Disorders and Stroke (NINDS); Children's...RecruitingNeurofibromatosis 1 | Neurofibromatosis Type 1 | NF1United States
-
Guy's and St Thomas' NHS Foundation TrustRecruitingNeurofibromatosis Type 1United Kingdom
-
University Hospital, Strasbourg, FranceRecruitingNeurofibromatosis Type 1France
-
National Cancer Institute (NCI)CompletedNeurofibroma | Neurofibromatosis Type 1United States
-
SpringWorks Therapeutics, Inc.AvailableNeurofibromatosis Type 1-Associated Plexiform Neurofibromas | Histiocytic Neoplasm | Other MAP-K Pathway Driven Diseases
-
AstraZenecaCompletedHealthy Participants | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)United States
-
Massachusetts Eye and Ear InfirmaryNo longer availableNeurofibromatosis Type 2 | Severe Profound Sensorineural Hearing LossUnited States
-
AstraZenecaMerck Sharp & Dohme LLCRecruitingNeurofibromatosis Type 1United States, Spain, Germany, Russian Federation, Japan, Italy, Netherlands
-
Shriners Hospitals for ChildrenCompletedNeurofibromatosis Type 1United States
-
Washington University School of MedicineCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
KU LeuvenUnknownNeurofibromatosis Type 1Belgium
-
Kristina HardyChildren's Hospital Los Angeles; Sydney Children's Hospitals Network; Royal Children... and other collaboratorsCompletedNeurofibromatosis Type 1United States
-
Erasmus Medical CenterUniversitaire Ziekenhuizen KU Leuven; ZonMw: The Netherlands Organisation for... and other collaboratorsTerminatedNeurofibromatosis Type 1Spain, Belgium, Netherlands
-
Massachusetts General HospitalCompletedNeurofibromatosis Type 1 | Cutaneous NeurofibromasUnited States
-
John Jay High SchoolUnknownNeurofibromatosis Type 1United States
-
AstraZenecaApproved for marketingNF type1 With Inoperable Plexiform NeurofibromasUnited States
-
AlexionRecruiting